Joint TDR/EC expert consultation on biomarkers in tuberculosis

Geneva, Switzerland, 2–3 July 2008

ISBN:	978 92 4 159794
Date:	02-03 July 2008
PDF [6.20 MB, 136 pages] Download \| Order print copy

Summary

Report of the joint TDR/EC expert consultation to evaluate the potential roles of biomarkers in the management of HIV-infected and HIV-uninfected patients with tuberculosis

The emergence of multi- and extensively drug resistant tuberculosis has aggravated the impact of TB, especially on HIV-infected individuals, and added urgency to the search for new vaccines, diagnostics and drugs. However the lack of suitable and validated biomarkers to assess areas of clinical management of TB patients remains a major obstacle to these efforts. This report provides an overview of biomarkers currently under study, treatment response and outcomes, technological platform s, and collaborations between researchers and funding agencies.